Choose from Opioid Awareness stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Choose from Opioid Illustration stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Could sex hormones explain the difference in opioid use and misuse between genders? Since 1999, the American opioid epidemic has killed more than half a million people, and according to the ...

At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...

PEOPLE RAVAGED BY THE OVERDOSE CRISIS. IN THE LAST TWO YEARS, MORE THAN 4000 PEOPLE HAVE DIED FROM OPIOID RELATED OVERDOSES IN MASSACHUSETTS. AND DURING THAT SAME TIME PERIOD, OUR CITIES AND TOWNS ...

Feb. 25, 2025 – Planning surgery? Talking to your doctor about pain management beforehand could keep you off the path to long-term opioid use, a risk factor for addiction. If the operation is ...

Get Instant Summarized Text (Gist) The combination of prescribed stimulants and opioids is linked to increased opioid doses, potentially contributing to a "twin epidemic" of drug use. Analysis of ...

RICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

Purdue could take additional funds from the Sacklers' future sale of their other companies like Mundipharma, which sold opioids outside of the U.S. Those sales will happen outside of Purdue's ...

The changes aim to shorten the time to achieve treatment effects in patients with opioid use disorder. The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible ...